Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok
Clinical trial NCT00539981 · COMPLETED
Trial details
- NCT number
- NCT00539981
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-15
- Primary completion
- 2008-05-28
- Enrollment
- 4648
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.